Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucus viscosity is a measure of the thickness and stickiness of mucus, a viscoelastic secretion present at mucosal surfaces throughout the body. It arises from the concentration, structure, and interactions of gel-forming mucins, DNA, proteins, lipids, and water[1][4][6]. Physiologically, mucus viscosity is crucial for effective mucociliary or peristaltic clearance and for forming protective barriers that trap pathogens and particulates while allowing selective passage of water, gases, and nutrients[1][3][4][6]. Alterations or pathological increases in mucus viscosity underlie several diseases, particularly in the airways (e.g., cystic fibrosis, COPD, asthma), by impairing clearance and promoting infection and tissue damage[4][6]. Drugs that modulate mucus viscosity include mucolytics, enzymes, and hydrators, which can alter the molecular structure or water content of mucus to restore or reduce its viscosity, thereby improving clearance or drug delivery[4][6]. However, excessive reduction in viscosity may compromise the barrier function of mucus[4]. Summary: "Mucus viscosity" is a functional property, not a discrete therapeutic molecular target or receptor. It describes the biophysical characteristics arising from multiple interacting components of mucus. The misattribution of "mucus viscosity" as a canonical target is incorrect.
Decrease viscosity by breaking disulfide bonds in mucins (e.g., N-acetylcysteine)[4]; Decrease viscosity by enzymatic degradation of DNA in sputum (e.g., dornase alfa)[4]; Increase hydration of mucus to reduce viscosity (e.g., hypertonic saline, mannitol)[4]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucus Viscosity.